Ligand(LGND) - 2024 Q1 - Earnings Call Transcript

Thank you, Michael and welcome everyone to our first quarter 2024 earnings call. I'm pleased to report a strong start to 2024. We continue to deliver on our strategy of enabling the clinical development of high value medicines by entering well-structured financial and licensing partnerships. I am happy to say that over the last year we have executed on this strategy, which we expect will propel Ligand into the next stage of growth. I'm excited about our prospects. Slide 3 summarizes our financial and portfo ...